In a study examining the combined effects of radiation and PD-L1 inhibitors in mouse models of breast and colon cancer, it has been found that combination therapy can effectively elicit CD8+ T cell responses, optimize the tumor immune microenvironment and control tumor growth [170]. Here, CD8A is linked to neoplasm.